These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28657488)

  • 1. The risks associated with the use of lamotrigine during pregnancy.
    Kong L; Zhou T; Wang B; Gao Z; Wang C
    Int J Psychiatry Clin Pract; 2018 Mar; 22(1):2-5. PubMed ID: 28657488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood stabilizers in pregnancy: a systematic review.
    Galbally M; Roberts M; Buist A;
    Aust N Z J Psychiatry; 2010 Nov; 44(11):967-77. PubMed ID: 21034180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from an Urban Maternal Mental Health Centre in New Zealand.
    Prakash C; Hatters-Friedman S; Moller-Olsen C; North A
    Psychopharmacol Bull; 2016 Aug; 46(2):63-69. PubMed ID: 27738382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal outcomes with the use of lamotrigine for bipolar disorder in pregnancy and breastfeeding: a case series and review of the literature.
    Wakil L; Epperson CN; Gonzalez J; O'Reardon JP; Kim DR
    Psychopharmacol Bull; 2009; 42(3):91-8. PubMed ID: 19752842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mood stabilisers and pregnancy outcomes - a review].
    Costoloni G; Pierantozzi E; Goracci A; Bolognesi S; Fagiolini A
    Psychiatr Pol; 2014; 48(5):865-87. PubMed ID: 25639010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine in bipolar disorder: efficacy during pregnancy.
    Newport DJ; Stowe ZN; Viguera AC; Calamaras MR; Juric S; Knight B; Pennell PB; Baldessarini RJ
    Bipolar Disord; 2008 May; 10(3):432-6. PubMed ID: 18402631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Teratogenic effects of lamotrigine in women with bipolar disorder].
    Berwaerts K; Sienaert P; De Fruyt J
    Tijdschr Psychiatr; 2009; 51(10):741-50. PubMed ID: 19821242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Peripartum Bipolar Disorder.
    Clark CT; Wisner KL
    Obstet Gynecol Clin North Am; 2018 Sep; 45(3):403-417. PubMed ID: 30092918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar disorder during pregnancy.
    Cohen LS
    J Clin Psychiatry; 2007; 68 Suppl 9():4-9. PubMed ID: 17764378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine and GABAA receptor modulators interact with menstrual cycle phase and oral contraceptives to regulate mood in women with bipolar disorder.
    Robakis TK; Holtzman J; Stemmle PG; Reynolds-May MF; Kenna HA; Rasgon NL
    J Affect Disord; 2015 Apr; 175():108-15. PubMed ID: 25601310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine-induced tactile hallucination.
    Oh HK; Tibrewal P; Dhillon R
    J Clin Psychiatry; 2014 Nov; 75(11):e1330. PubMed ID: 25470104
    [No Abstract]   [Full Text] [Related]  

  • 12. Teratogenesis associated with antibipolar agents.
    Nguyen HT; Sharma V; McIntyre RS
    Adv Ther; 2009 Mar; 26(3):281-94. PubMed ID: 19330496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine dosing for pregnant patients with bipolar disorder.
    Clark CT; Klein AM; Perel JM; Helsel J; Wisner KL
    Am J Psychiatry; 2013 Nov; 170(11):1240-7. PubMed ID: 24185239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects.
    Tosato S; Albert U; Tomassi S; Iasevoli F; Carmassi C; Ferrari S; Nanni MG; Nivoli A; Volpe U; Atti AR; Fiorillo A
    J Clin Psychiatry; 2017 May; 78(5):e477-e489. PubMed ID: 28297592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar Disorder in Pregnancy: A Review of Pregnancy Outcomes.
    Scrandis DA
    J Midwifery Womens Health; 2017 Nov; 62(6):673-683. PubMed ID: 29083536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.
    Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB
    Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine for the treatment of bipolar disorder.
    Engle PM; Heck AM
    Ann Pharmacother; 2000 Feb; 34(2):258-62. PubMed ID: 10676836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative management of women with bipolar disorder during pregnancy and postpartum: pharmacologic considerations.
    Ward S; Wisner KL
    J Midwifery Womens Health; 2007; 52(1):3-13. PubMed ID: 17207745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications.
    Seo HJ; Chiesa A; Lee SJ; Patkar AA; Han C; Masand PS; Serretti A; Pae CU
    Clin Neuropharmacol; 2011; 34(1):39-47. PubMed ID: 21242744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor neonatal adaptation following in-utero exposure to quetiapine and lamotrigine.
    Lau C; Watson H; Cheong J
    J Obstet Gynaecol; 2015; 35(6):646. PubMed ID: 25642636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.